Capivasertib Impurity 27 | CAS 688362-54-1 - Request Quote
Capivasertib Impurity 27
| SZ CAT No: | SZ-C254037 |
| CAS No | 688362-54-1 |
| Mol.F. | C9H10ClN |
| Mol.Wt. | 167.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Capivasertib Impurity 27 is chemically 1-(4-Chlorophenyl)prop-2-en-1-amine. Capivasertib Impurity 27 is supplied with detailed characterization data compliant with regulatory guideline. Capivasertib Impurity 27 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Capivasertib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 688362-54-1
Purchase 688362-54-1
Order 688362-54-1
Enquire 688362-54-1
price of 688362-54-1
688362-54-1 Supplier
688362-54-1 Manufacturer
688362-54-1 Exporter
buy high quality Capivasertib Impurity 27
Purchase Capivasertib Impurity 27
Capivasertib Impurity 27 suppliers
Capivasertib Impurity 27 manufacturers
Capivasertib Impurity 27 price
Order Capivasertib Impurity 27
Enquire Capivasertib Impurity 27
Capivasertib Impurity 27 cost
Capivasertib Impurity 27 Supplier
Capivasertib Impurity 27 Distributor
Capivasertib Impurity 27 for Method Validation
Capivasertib Reference Standard
Capivasertib Impurity 27 for ANDA Filing
Capivasertib Impurity 27 for Forced Degradation Studies
Capivasertib Impurity 27 Identification Standards
Capivasertib Impurity 27 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


